765 participants
NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-05
- Start Date:
- 2026-08-30
- Completion:
- 2033-03-31
Conditions
- Breast Cancer
- Triple-negative Breast Cancer
Interventions
- DRUG
No Results Yet